Cite
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
MLA
Tengvall, Katarina, et al. “Molecular Mimicry between Anoctamin 2 and Epstein-Barr Virus Nuclear Antigen 1 Associates with Multiple Sclerosis Risk.” Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 34, Aug. 2019, pp. 16955–60. EBSCOhost, https://doi.org/10.1073/pnas.1902623116.
APA
Tengvall, K., Huang, J., Hellström, C., Kammer, P., Biström, M., Ayoglu, B., Lima Bomfim, I., Stridh, P., Butt, J., Brenner, N., Michel, A., Lundberg, K., Padyukov, L., Lundberg, I. E., Svenungsson, E., Ernberg, I., Olafsson, S., Dilthey, A. T., Hillert, J., … Kockum, I. (2019). Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proceedings of the National Academy of Sciences of the United States of America, 116(34), 16955–16960. https://doi.org/10.1073/pnas.1902623116
Chicago
Tengvall, Katarina, Jesse Huang, Cecilia Hellström, Patrick Kammer, Martin Biström, Burcu Ayoglu, Izaura Lima Bomfim, et al. 2019. “Molecular Mimicry between Anoctamin 2 and Epstein-Barr Virus Nuclear Antigen 1 Associates with Multiple Sclerosis Risk.” Proceedings of the National Academy of Sciences of the United States of America 116 (34): 16955–60. doi:10.1073/pnas.1902623116.